TC BioPharm (Holdings) PLC (TCBP)
0.7349
-0.06
(-8.07%)
USD |
NASDAQ |
Jun 25, 16:00
0.7349
0.00 (0.00%)
After-Hours: 20:00
TC BioPharm Accounts Payable (Quarterly): 2.434M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.434M |
| June 30, 2023 | 1.203M |
| December 31, 2022 | 1.068M |
| June 30, 2022 | 2.049M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.920M |
| September 30, 2021 | 1.842M |
| December 31, 2020 | 0.87M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.87M
Minimum
Dec 2020
2.434M
Maximum
Mar 2024
1.626M
Average
1.842M
Median
Sep 2021
Accounts Payable (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 6.587M |
| Biodexa Pharmaceuticals Plc | 0.40M |
| NuCana PLC | 7.277M |
| Autolus Therapeutics PLC | 1.399M |
| Verona Pharma PLC | 4.651M |